STATE STREET CORP - HORIZON PHARMA PLC ownership

HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 192 filers reported holding HORIZON PHARMA PLC in Q2 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of HORIZON PHARMA PLC
ValueSharesWeighting
Q1 2019$100,392,000
+42.7%
3,798,424
+5.5%
0.01%
+33.3%
Q4 2018$70,353,000
-5.9%
3,600,455
-5.7%
0.01%0.0%
Q3 2018$74,781,000
+17.6%
3,818,944
-0.5%
0.01%
+20.0%
Q2 2018$63,568,000
+18.6%
3,838,449
+1.7%
0.01%0.0%
Q1 2018$53,593,000
-9.2%
3,774,293
-6.7%
0.01%0.0%
Q4 2017$59,051,000
+3.2%
4,044,425
-10.4%
0.01%0.0%
Q3 2017$57,240,000
-1.7%
4,513,960
-8.0%
0.01%0.0%
Q2 2017$58,241,000
-10.1%
4,906,307
+12.0%
0.01%
-16.7%
Q1 2017$64,766,000
-7.8%
4,382,120
+1.0%
0.01%
-14.3%
Q4 2016$70,222,000
-8.6%
4,339,978
+2.4%
0.01%
-12.5%
Q3 2016$76,810,000
+11.0%
4,236,544
+0.8%
0.01%
+14.3%
Q2 2016$69,194,000
+147.6%
4,201,164
+149.1%
0.01%
+133.3%
Q1 2016$27,950,000
-25.6%
1,686,734
-2.7%
0.00%
-25.0%
Q4 2015$37,553,000
+43.6%
1,732,843
+31.3%
0.00%
+33.3%
Q3 2015$26,154,000
-38.6%
1,319,497
+7.6%
0.00%
-40.0%
Q2 2015$42,593,000
-39.4%
1,226,095
-54.7%
0.01%
-28.6%
Q1 2015$70,269,000
+57.1%
2,705,746
-22.0%
0.01%
+75.0%
Q4 2014$44,735,000
-1.4%
3,470,413
-6.0%
0.00%
-20.0%
Q3 2014$45,355,0003,693,7250.01%
Other shareholders
HORIZON PHARMA PLC shareholders Q2 2017
NameSharesValueWeighting ↓
Broadfin Capital, LLC 5,959,819$96,430,00010.71%
Consonance Capital Management LP 5,793,903$93,745,00010.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 8,956,988$144,924,0005.96%
JW Asset Management, LLC 507,075$8,205,0005.46%
KINGDON CAPITAL MANAGEMENT, L.L.C. 6,682,618$108,125,0005.23%
NEXTHERA CAPITAL LP 500,000$8,090,0004.74%
Lion Point Capital, LP 1,164,414$18,840,0004.58%
KINGDON CAPITAL MANAGEMENT, L.L.C. 4,503,900$72,873,0003.52%
ARMISTICE CAPITAL, LLC 650,000$10,517,0002.49%
SCOPIA CAPITAL MANAGEMENT LP 8,081,650$130,761,0002.48%
View complete list of HORIZON PHARMA PLC shareholders